Delaware
(State or other jurisdiction of incorporation or organization)
|
0-19437
(Commission
File Number)
|
11-2962080
(I.R.S. Employer
Identification Number) |
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class | Trading symbol | Name of each exchange on which registered | ||
Common Stock
$0.001 par value per share
|
ASXC | NYSE American |
Item 1.01
|
Entry into a Material Definitive Agreement.
|
(d)
|
Exhibits.
|
Exhibit No.
|
Description
|
10.1
|
|
104
|
Cover Page Interactive Data File (formatted in inline XBRL)
|
|
ASENSUS SURGICAL, INC.
|
|
|
|
|
|
|
|
Date: April 30, 2021
|
/s/ Shameze Rampertab
|
|
|
Shameze Rampertab
|
|
|
EVP and Chief Financial Officer
|
|
Exhibit 10.1
Non-Employee Director Compensation Program
Effective July 1, 2021, the Asensus Surgical, Inc. Non-Employee Director Compensation Program is:
(1) |
Annual non-employee director compensation limit of $250,000 with initial year compensation limit of $500,000 as set forth in the Amended and Restated Equity Compensation Plan (the “Plan”). |
(2) |
Number of shares of common stock, restricted stock units or stock options calculated using a stock price equal to the greater $1.00 or the average closing price in the 20 trading days prior to the date of grant and, for stock options, if elected by a director, a Black Scholes calculation. Stock options will have a seven-year term. |